|
C7ORF44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.581680E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.816500E-02 |
| Normal-vs-Stage2 |
5.243600E-01 |
| Normal-vs-Stage3 |
1.997280E-04 |
| Normal-vs-Stage4 |
7.745700E-02 |
| Stage1-vs-Stage2 |
1.254780E-01 |
| Stage1-vs-Stage3 |
3.787900E-02 |
| Stage1-vs-Stage4 |
8.036400E-01 |
| Stage2-vs-Stage3 |
1.279730E-02 |
| Stage2-vs-Stage4 |
1.116580E-01 |
| Stage3-vs-Stage4 |
1.498580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.156300E-02 |
| Normal-vs-AfricanAmerican |
1.394320E-02 |
| Normal-vs-Asian |
7.670800E-01 |
| Caucasian-vs-AfricanAmerican |
3.424800E-01 |
| Caucasian-vs-Asian |
7.356200E-01 |
| AfricanAmerican-vs-Asian |
4.175200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.635700E-02 |
| Normal-vs-Female |
1.311880E-02 |
| Male-vs-Female |
5.938600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.080400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.142200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.280850E-01 |
| Normal-vs-Age(81-100Yrs) |
6.945600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.817600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.842400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.540380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.199600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.792200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.318000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.848600E-04 |
| Normal-vs-Grade 2 |
2.736300E-02 |
| Normal-vs-Grade 3 |
5.713900E-02 |
| Normal-vs-Grade 4 |
6.956300E-03 |
| Grade 1-vs-Grade 2 |
1.615500E-02 |
| Grade 1-vs-Grade 3 |
1.133890E-02 |
| Grade 1-vs-Grade 4 |
1.173590E-01 |
| Grade 2-vs-Grade 3 |
7.596400E-01 |
| Grade 2-vs-Grade 4 |
2.889000E-01 |
| Grade 3-vs-Grade 4 |
1.942970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.993800E-02 |
| Normal-vs-ccB subtype |
3.138800E-01 |
| ccA subtype-vs-ccB subtype |
5.121400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.177200E-01 |
| Normal-vs-N1 |
3.429800E-01 |
| N0-vs-N1 |
8.898000E-01 |
|
|
